This paper is in the following e-collection/theme issue:

Decision Support for Health Professionals (1195) Clinical Information and Decision Making (1418) Focus Groups and Qualitative Research for Human Factors Research (862)

Published on in Vol 8, No 12 (2020): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/23530, first published .
Cystic Fibrosis Point of Personalized Detection (CFPOPD): An Interactive Web Application

Cystic Fibrosis Point of Personalized Detection (CFPOPD): An Interactive Web Application

Cystic Fibrosis Point of Personalized Detection (CFPOPD): An Interactive Web Application

Authors of this article:

Christopher Wolfe1 Author Orcid Image ;   Teresa Pestian1 Author Orcid Image ;   Emrah Gecili1 Author Orcid Image ;   Weiji Su1, 2 Author Orcid Image ;   Ruth H Keogh3 Author Orcid Image ;   John P Pestian4, 5 Author Orcid Image ;   Michael Seid4, 6, 7 Author Orcid Image ;   Peter J Diggle8, 9 Author Orcid Image ;   Assem Ziady4, 6 Author Orcid Image ;   John Paul Clancy4, 6, 10 Author Orcid Image ;   Daniel H Grossoehme11, 12, 13 Author Orcid Image ;   Rhonda D Szczesniak1, 4, 6 Author Orcid Image ;   Cole Brokamp1, 4 Author Orcid Image
Article Authors Cited by (4) Tweetations (3) Metrics

Journals

  1. Guimbellot J, Nichols D, Brewington J. Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis. Clinics in Chest Medicine 2022;43(4):617 View
  2. Zhou G, Wang Z, Palipana A, Andrinopoulou E, Miranda Afonso P, McPhail G, Siracusa C, Gecili E, Szczesniak R. Predicting lung function decline in cystic fibrosis: the impact of initiating ivacaftor therapy. Respiratory Research 2024;25(1) View
  3. Wang Z, Zhou G, Palipana A, Gecili E, Dexheimer J, Siracusa C, Szczesniak R. Secular and modulator-specific drifts in the predictive performance of a rapid lung function decline algorithm: a cystic fibrosis patient registry study. Discover Data 2024;2(1) View